Home > PE Ratio > AAREY DRUGS & PHARMACEUTICALS

AAREY DRUGS & PHARMACEUTICALS
PE (Price/Earnings) Ratio

The Current P/E Ratio of AAREY DRUGS & PHARMACEUTICALS is 56.59.

Share Price ₹82.8Aug 13,2026
Market Cap ₹255.9 Cr
Earnings-TTM₹4.5 CrTTM-Standalone Results
Price/Earnings56.59xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for AAREY DRUGS & PHARMACEUTICALS
Please provide your vote to see the results
AAREY DRUGS & PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of AAREY DRUGS & PHARMACEUTICALS

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of AAREY DRUGS & PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹255.9 Cr] as on Aug 13,2026

(/) Earnings [ ₹4.5 Cr] based on TTM-Standalone Results

(=) P/E Ratio [ 56.59x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for AAREY DRUGS & PHARMACEUTICALS , the investors are currently willing to pay 56.59 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of AAREY DRUGS & PHARMACEUTICALS !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of AAREY DRUGS & PHARMACEUTICALS over the last five years.

Historical PE (Price/Earnings) ratio chart of AAREY DRUGS & PHARMACEUTICALS


PE Ratio Performance Analysis for AAREY DRUGS & PHARMACEUTICALS

- AAREY DRUGS & PHARMACEUTICALS 's latest p/e ratio is 56.59x.

- AAREY DRUGS & PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 18.18x.

- AAREY DRUGS & PHARMACEUTICALS 's operated at median p/e ratio of 16.03x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, AAREY DRUGS & PHARMACEUTICALS 's p/e ratio peaked in Mar2024 at 26.76x.

- AAREY DRUGS & PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2021 of 8.33x.


How does AAREY DRUGS & PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Trading Industry?

Peer Comparison (Trading Industry)Earnings-TTM (Cr)PE RatioMarket Cap
AAREY DRUGS & PHARMACEUTICALS 4.5256.59255.9
ADANI ENTERPRISES LTD7,230.0655.34400,147.0
PREMIER ENERGIES LTD1,668.3928.0546,802.4
ADITYA INFOTECH LTD477.2891.8243,825.6
AEGIS LOGISTICS LTD1,476.1129.6643,787.2
REDINGTON LTD1,504.6617.9627,022.0
RRP SEMICONDUCTOR LTD-7.75-1,516.4011,758.2
HONASA CONSUMER LTD249.4062.6315,619.8
LLOYDS ENTERPRISES LTD235.7749.2911,620.1
MMTC LTD269.1335.609,582.0
CELLO WORLD LTD324.2625.208,170.5

Trading Industry Benchmark (Top 10) PE Analysis vs AAREY DRUGS & PHARMACEUTICALS 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE -1,516.40x
Max industry PE 91.82x
Median industry PE 35.60x
Average industry PE -96.75x



You may also like the below Video Courses